The companies submitted Phase III clinical trial data to FDA as a supplemental application for their vaccine, which is already approved for adults and children as young as 16.
Pfizer and BioNTech ask FDA to approve their Covid-19 vaccine for kids as young as 12
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться